SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Great-West Lifeco Inc. (GWLIF) trades at a trailing P/E of 11.8, forward P/E of 9.1. Trailing earnings yield is 8.47%, forward earnings yield 10.98%. PEG 9.84.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (11.8); earnings yield beats bond yields (8.47%).
- Forward P/E 9.1 (down from trailing 11.8) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 9.84 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 8.47% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 10.98% as earnings recover.
Overall SharesGrow Score: 72/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GWLIF
Valuation Multiples
P/E (TTM)11.8
Forward P/E9.1
PEG Ratio9.84
Forward PEG0.31
P/B Ratio0.00
P/S Ratio1.20
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.26
Forward EPS (Est.)$5.52
Book Value / Share$0.00
Revenue / Share$42.10
FCF / Share$0.00
Yields & Fair Value
Earnings Yield8.47%
Forward Earnings Yield10.98%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.66 |
$46.38B |
$2.76B |
6% |
| 2017 |
$2.17 |
$47.01B |
$2.28B |
4.8% |
| 2018 |
$3.13 |
$44.03B |
$3.09B |
7% |
| 2019 |
$2.49 |
$44.7B |
$2.49B |
5.6% |
| 2020 |
$3.17 |
$60.6B |
$3.08B |
5.1% |
| 2021 |
$3.36 |
$64.45B |
$3.26B |
5.1% |
| 2022 |
$3.86 |
$44.7B |
$3.73B |
8.3% |
| 2023 |
$2.93 |
$21.68B |
$2.87B |
13.2% |
| 2024 |
$4.21 |
$17.22B |
$4.07B |
23.6% |
| 2025 |
$4.26 |
$39.1B |
$4.12B |
10.5% |
